Novartis Ag Adr Stock Analysis

Novartis Stock Analysis Notes

The company recorded earning per share (EPS) of 5.88. Novartis AG ADR last dividend was issued on the 12th of March 2025. The entity had 1116:1000 split on the 9th of April 2019. Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Novartis operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 108000 people. To find out more about Novartis AG ADR contact Richard Saynor at 41 61 324 11 11 or learn more at https://www.novartis.com.

Novartis AG ADR Upcoming and Recent Events

Novartis Thematic Classifications

Novartis Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 224.85 B.

Novartis Profitablity

The company has Net Profit Margin of 0.23 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.3 %, which entails that for every 100 dollars of revenue, it generated $0.3 of operating income.

Technical Drivers

As of the 22nd of March, Novartis secures the Downside Deviation of 1.24, risk adjusted performance of 0.1914, and Mean Deviation of 0.9686. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novartis AG ADR, as well as the relationship between them. Please verify Novartis AG ADR jensen alpha and semi variance to decide if Novartis AG ADR is priced some-what accurately, providing market reflects its recent price of 112.13 per share. Given that Novartis AG ADR has jensen alpha of 0.298, we recommend you to check Novartis's last-minute market performance to make sure the company can sustain itself at a future point.

Novartis AG ADR Price Movement Analysis

Novartis Outstanding Bonds

Novartis Predictive Daily Indicators

Novartis Forecast Models

Novartis' time-series forecasting models are one of many Novartis' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novartis' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Novartis prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novartis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Novartis. By using and applying Novartis Stock analysis, traders can create a robust methodology for identifying Novartis entry and exit points for their positions.

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.